Skin autofluorescence predicts major adverse cardiovascular events in patients with type 1 diabetes: a 7-year follow-up study
C. Blanc-Bisson(Hôpital Cardiologique du Haut-Lévêque), Vincent Rigalleau(Université de Bordeaux), Kalina Rajaobelina(Université de Bordeaux), Fritz‐Line Vélayoudom‐Céphise(Hôpital Cardiologique du Haut-Lévêque), Marie Monlun(Hôpital Cardiologique du Haut-Lévêque), Audrey Cougnard‐Grégoire(University of Manchester), L. Alexandre(Hôpital Cardiologique du Haut-Lévêque), Cécile Delcourt(Université de Bordeaux), Catherine Helmer(Inserm), Laurence Blanco(Hôpital Cardiologique du Haut-Lévêque), Kamel Mohammedi(Hôpital Cardiologique du Haut-Lévêque)
Cited by 44
Related Papers
The changing prevalence and incidence of dementia over time — current evidence
|Nature Reviews Neurology|2017|773
ω-3 Polyunsaturated Fatty Acid Biomarkers and Coronary Heart Disease
|JAMA Internal Medicine|2016|405
Biomarkers of Dietary Omega-6 Fatty Acids and Incident Cardiovascular Disease and Mortality
|Circulation|2019|335
Trial of Lixisenatide in Early Parkinson’s Disease
|New England Journal of Medicine|2024|302
Blood n-3 fatty acid levels and total and cause-specific mortality from 17 prospective studies
|Nature Communications|2021|241